USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-21 обновлены отчеты компании RGLS: 2023 ∙ 2022
  1. Главная
  2. Котировки акций
  3. Regulus Therapeutics
  4. Мультипликаторы
Regulus Therapeutics logo
Regulus Therapeutics RGLS
$ 2.55 5.37%
mail-toСообщить о неточности

Regulus Therapeutics Мультипликаторы 2011-2024 | RGLS

Мультипликаторы по годам Regulus Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -1.8 -0.6 -0.1 -3.1 -1.0 -0.2 -1.3 -0.8 -5.3 -14.9 -19.0 -2.8 -

P/S

 - - - 4.9 2.7 113.8 1316.5 57.5 14.3 110.1 18.1 3.9 -

EPS

 1.6 1.9 3.2 -0.5 -1.1 -5.6 -1.0 -1.6 -1.1 -1.3 -0.5 -2.1 -85.8

EV (Enterprise Value)

 38.5 млн 6.14 млн -44.1 млн 29.1 млн 6.59 млн 28 млн 124 млн 98.3 млн 298 млн 846 млн 367 млн 50 млн 75.2 млн

EBITDA per Share

 -1.63 -1.84 -3.19 -0.391 -0.921 -5.1 -10.8 -18 -12.4 -11.8 -5.13 -16.9 -

EV/EBITDA

 1.7 -1.6 0.1 -0.2 -1.5 -0.9 -5.3 -19.7 -21.2 -1.6 -

PEG

 -0.02 -0.01 -0.0 -0.05 -0.01 -0.0 -0.03 0.02 -0.33 0.09 -0.25 0.01 -

P/B

 2.5 0.5 0.0 1.9 0.9 -1.4 2.7 1.2 2.4 6.4 3.8 0.8 -

P/CF

 -2.0 -0.7 -0.1 -3.9 -0.9 -0.2 -1.6 -1.2 -5.8 -20.7 -12.2 -4.8 -

ROE %

 -141.77 -85.08 -50.60 -60.44 -92.89 832.06 -204.18 -145.94 -44.93 -42.93 -19.97 -28.04 -

ROA %

 -97.68 -60.63 -40.62 -41.83 -44.18 -174.42 -92.41 -81.30 -39.51 -33.05 -15.17 -16.82 -

ROCE %

 -146.83 -84.82 -50.61 -54.39 -82.19 -3650.51 -155.13 -93.84 -42.63 -32.95 -15.80 -13.86 -

Current Ratio

 3.2 3.5 5.1 3.2 1.9 0.7 2.0 6.3 10.6 4.7 11.3 7.7 -

DSO

 - - - 18.3 61.0 131.8 1890.9 506.5 176.2 13.0 1.5 - -

DIO

 - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - -

Операционный цикл

 - - - - - - - - - - - - -

Финансовый цикл

 - - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Regulus Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.4 -0.37 -0.42 - -0.5 -0.5 -0.46 - -0.1 -0.78 -0.08 -0.03 -0.04 -0.23 -0.25 -0.23 -0.26 -0.3 -0.31 -0.98 -1.18 -1.59 -1.85 -1.67 -2.11 -0.41 -0.38 -0.38 -0.37 -0.4 -0.4 -0.14 -0.25 -0.41 -0.29 -0.47 -0.23 -0.28 -0.3 -0.05 -0.05 -0.2 -0.2 -0.22 -15.98 -10.78 -13.06 -14.81 -11.68 -28.98 -45.64

EBITDA per Share

 - - -0.43 - -0.51 -0.49 -0.45 - -0.1 -0.81 -0.08 - -0.02 -0.21 -0.22 - -0.2 -0.24 -0.22 - -0.94 -1.41 -1.73 - -1.79 -0.38 -0.36 - -0.33 -0.38 -0.4 - -0.23 -0.4 -0.25 - -0.24 -0.28 -0.24 - -0.05 -0.11 -0.15 - -0.01 -0.01 -0.01 - -3.54 - -

ROE %

 -94.19 -85.54 -82.04 -49.81 -79.55 -90.26 -89.51 -68.30 -73.38 -49.50 -59.81 -60.44 -79.81 -101.05 -99.41 -92.89 77.83 280.41 542.01 832.05 644.74 424.31 126.41 -204.18 -198.86 -188.72 -164.97 -145.94 -116.06 -91.73 -71.07 -44.93 -55.90 -52.84 -44.96 -42.93 -28.20 -23.10 -21.89 -19.97 -28.99 -35.83 -32.15 -28.04 -12.11 -0.43 3.75 4.86 2.52 - -

ROA %

 -56.08 -48.72 -46.02 -37.75 -44.43 -64.48 -63.29 -47.32 -50.84 -34.85 -41.13 -41.83 -49.94 -58.78 -52.22 -44.18 -63.22 -87.11 -124.78 -174.41 -162.32 -145.88 -124.06 -92.41 -93.73 -92.78 -85.96 -81.30 -66.53 -56.36 -50.31 -39.51 -47.32 -43.82 -35.89 -33.05 -21.69 -17.74 -16.73 -15.17 -20.25 -23.98 -20.52 -16.82 -14.87 -11.82 -9.31 -4.70 -2.44 - -

ROCE %

 -97.04 -87.35 -82.77 -49.34 -78.36 -88.31 -89.40 -68.43 -72.64 -47.83 -54.76 -50.43 -75.38 -96.12 -94.48 -61.95 106.38 299.66 550.93 662.47 618.70 406.60 118.12 -160.23 -194.45 -184.90 -162.16 -110.13 -120.89 -97.42 -76.71 -38.20 -47.03 -45.11 -37.89 -26.80 -29.91 -24.18 -19.34 -14.06 -19.75 -22.33 -21.43 -13.32 -10.97 -2.94 1.18 - 2.34 - -

Current Ratio

 4.0 4.5 3.5 3.5 - 4.5 5.2 5.1 3.1 3.9 3.1 3.2 3.2 3.2 3.2 1.9 1.9 1.9 1.9 0.8 0.8 0.8 0.8 1.8 1.8 1.8 1.8 2.3 2.3 2.3 2.3 8.3 8.3 8.3 8.3 4.3 4.3 4.3 4.3 4.2 4.2 4.2 4.2 2.5 2.5 2.5 2.5 1.0 1.0 - -

DSO

 - - - - - - - - - - - 9.2 9.2 - 12501.2 5784.2 5784.2 5784.2 7.9 131.8 131.8 131.8 1011.4 1890.9 1890.9 1890.9 5145.5 8400.1 741.2 313.1 1089.6 84.2 490.3 238.5 111.8 5.9 23.1 34.0 9.9 1.5 19.6 25.1 1.1 - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

 - - - - - - - - - - - 9.2 9.2 - 12501.2 5784.2 5784.2 5784.2 7.9 131.8 131.8 131.8 1011.4 1890.9 1890.9 1890.9 5145.5 8400.1 741.2 313.1 1089.6 84.2 490.3 238.5 111.8 5.9 23.1 34.0 9.9 1.5 19.6 25.1 1.1 - - - - - - - -

Финансовый цикл

 - - - - - - - - - - - 9.2 9.2 - 12501.2 5784.2 5784.2 5784.2 7.9 131.8 131.8 131.8 1011.4 1890.9 1890.9 1890.9 5145.5 8400.1 741.2 313.1 1089.6 84.2 490.3 238.5 111.8 5.9 23.1 34.0 9.9 1.5 19.6 25.1 1.1 - - - - - - - -

Все данные представлены в валюте USD